Related Experiment Video
Updated: Sep 14, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
Jennifer Ward1, Kevin Armstrong2, Therese Min-Jung Kang1,3
1Alfred Health Radiation Oncology, School of Translational Medicine Monash University Melbourne VIC Australia.
Objectives:
To evaluate the patterns of management of clinical node-positive non-metastatic prostate cancer (cN1M0PC) at a population-based level over time, and to identify factors associated with the different management approaches.
Patients And Methods:
The study included men diagnosed with cN1M0PC in Prostate Cancer Outcome Registry Victoria (PCOR-Vic) in Australia between 2008 and 2022. The primary outcome was the use of local therapy (radical prostatectomy or prostate+/- pelvic radiation therapy) within the first 12 months of diagnosis. Multivariable logistic regressions were used to evaluate factors associated with local therapy use among all men and the likelihood of having a radical prostatectomy among men who had local therapy.
Results:
Of the 819 men included in this study, 52% had PSMA-PET staging, and this increased over time to 74% in 2018-2022. There were 530 (65%) who had local therapy (169 radical prostatectomy, and 361 radiation therapy), 259 (32%) had systemic therapy alone, and 30 (4%) did not have any treatment. There was an increase in the proportion of men who had local therapy over time, from 52% in 2008-2012 to 72% in 2018-2022. In multivariable analyses, increased age, higher PSA and residency in regional/remote areas were independently associated with lower likelihood of local therapy use, while PSMA-PET staging and more recent year of diagnosis were associated with higher likelihood of local therapy use. Of the 530 men who had local therapy, increased age, higher PSA, higher ISUP grade group and higher clinical T categories were associated with a lower likelihood of having radical prostatectomy while men diagnosed in private institutions and from higher socioeconomic quintiles were more likely to have radical prostatectomy.
Conclusion:
This is the largest contemporaneous population-based study on the management of cN1M0PC in the PSMA-PET era. There is an increasing use of local therapy for cN1M0PC over time, with large variations in practice.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023